Agendia’s MammaPrint® and BluePrint® Breast Cancer Tests Selected by Unicancer for French Patients

Product News   May 15, 2018

 
Agendia’s MammaPrint® and BluePrint® Breast Cancer Tests Selected by Unicancer for French Patients

Credit: Agendia

 
 
FURTHER INFORMATION
 
 
 

Related Product News

Owlstone Medical Appoints Five Leading Experts to Scientific Advisory Board

Product News

Additions form a key strategic resource to advise on Breath Biopsy platform, product, and study development.

READ MORE

Human Cell-Expressed Cytokines and Growth Factors

Product News

Proteintech has unveiled its new Humankine ® line of over 50 human cell-expressed cytokines and growth factors.

READ MORE

Axol Bioscience Launch Human iPSC-derived Atrial Cardiomyocytes

Product News

A consistent and reproducible model for drug development, toxicity testing and disease modelling applications.

READ MORE

Like what you just read? You can find similar content on the communities below.

Diagnostics Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy